Johnson & Johnson (JNJ) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Johnson & Johnson (JNJ) PT Raised to $140 at Stifel
April 17, 2019 8:43 AM EDTStifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $140.00 (from $135.00) while maintaining a Hold rating. 1Q19 sales and EPS outperformed expectations and management raised operational sales growth and underlying EPS outlooks. The results were buoyed by better-thanexpected Pharmaceutical and... More
Johnson & Johnson (JNJ) PT Raised to $147 at Raymond James
April 17, 2019 7:42 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $147.00 (from $145.00) while maintaining a Outperform rating.
growth was still much better than expected, which gives us more confidence in our estimates... MoreJohnson & Johnson (JNJ) PT Raised to $157 at BMO Capital
April 17, 2019 6:56 AM EDTBMO Capital analyst Joanne Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $157.00 (from $154.00) while maintaining a Outperform rating.
Staying On Course in Its Transition Year
tightening EPS to $8.53-$8.63 from $8.50-$8.65
... MoreJohnson & Johnson (JNJ) PT Raised to $150 at RBC Capital
April 17, 2019 6:37 AM EDTRBC Capital analyst Brandon Henry raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $144.00) while maintaining a Outperform rating.
Strong start to 2019; revised guidance appears conservative... More